about
Platelet changes following clinical and experimental hepatic homotransplantation.Fibrinolysis in leukaemia.ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase.Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.Epsilon-aminocaproic acid therapy in ulcerative colitis.THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEWStudies on the thrombolytic activity of human plasma.Localization of tissue plasminogen activator in the endothelium of a limited number of vesselsThe fibrinolytic enzyme system of the rat: the effect of aminonucleoside-induced nephrotic syndromeSome effects of proteolytic inhibitors on tissue injury and systemic anaphylaxis.Treatment of experimental pulmonary embolism by main pulmonary arterial infusion of a fibrinolytic agent.Effect of age, sex, and diurnal variation on the human fibrinolystic systemFibrinolytic activity in malignant disease.Effect of feeding fat on fibrinolysis, Stypven time, and platelet aggregation in Africans, Asians, and Europeans.The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases.Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity.The effect of age on the fibrinolytic enzyme system.COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.Effect of submaximal exercise on fibrinolytic activity in ischaemic heart disease.Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activityPredisposing factors to post-operative adhesion development.Purification of serine protease from polychaeta, Lumbrineris nipponica, and assessment of its fibrinolytic activity.Fibrinolytic activity evoked in the plasma of the normal and adrenalectomized rat by cellulose sulphate.The mechanism of clot dissolution by plasmin.The maintenance of a sustained thrombolytic state in man. I. Induction and effects.FIBRINOLYTIC ACTIVITY IN TYPHOID FEVER.Effects on blood coagulation, fibrinolysis, and platelet aggregation of normal and atheronatous aortic tissue.Method of estimating the inhibitory effect of plasma or serum upon urokinase-activated fibrinolysis.Studies on the fibrinolytic enzyme system in obesity.Effect of local exercise and vessel occlusion on fibrinolytic activity.Effect of feeding fat on fibrinolysis, stypven time, and platelet aggregation in elderly Africans.The fibrinolytic enzyme system in hypertension.THE EFFECT OF CALCIUM OF FIBRINOLYSIS IN VITRO.Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man.THE USE OF FIBRINOLYTIC ACTIVATORS IN MENINGITIS AND SIMILAR CONDITIONS.Symposium on Fibrinolysis.Effect of mental stress on the fibrinolytic reactivity to exercise.Idiopathic gangrene in African children.
P2860
Q33462427-4B52D571-6F6B-4A8A-8A3B-803CF33B8109Q33469558-F8B64B33-908D-430C-AAB6-7C4058E37A29Q33954645-73FA70B7-B5EA-4E7E-92A8-36F7A566CA6FQ34019757-19D455F8-B19B-45B4-9492-D3C72838BE95Q34276086-FF26D4B9-8C97-4595-ABE3-03458E235DD7Q34467577-2978183C-8B97-408F-B78F-A44EEAF33514Q35004538-BDA7F282-B1B5-447D-9800-F6A8A9DB0F39Q35462618-847394FF-9B18-47B1-A95F-615BFBEB07DDQ35564843-FC76BF4E-3913-4A82-ADC8-35CFE6B1254AQ35833922-53EB8556-8F86-49A5-94F5-E170AD2CA4D5Q36129221-BACC6DFB-16D5-4593-AA68-664FE3F44F26Q36265310-6E89CA2D-F5A4-43E9-A8A3-C432D4207961Q36480829-E7292637-11D3-432F-91FF-FDCF797DA7C1Q36525580-69350709-E575-41FB-A040-2EFB9AF9FB34Q36593908-A56D4EBF-D257-4EB2-A0E8-ED0FA96BEC0FQ36622117-BE7FB578-9ED1-44B7-86DE-A7822D24230DQ36632949-B09089F5-5F10-42F2-A9BB-3AC973014447Q36637755-25AFCC65-1E5B-449C-9D65-80D1C4D2C77EQ36659895-898F5C0D-9993-4F6D-B395-1A8D84DDEBA3Q36725711-3079585D-62D2-4C2E-81A4-74A0994CA0A0Q36792269-2239C3C5-96AB-40C5-ABD5-318C447D8DA2Q36993272-B2F8FF91-5E4E-4A52-8B8F-A0B316E13A71Q38455443-3FD28ED1-428B-47D2-96A9-13ECEACF5078Q38712672-C0F73CC9-F000-4C5D-A1F4-07DF9EFE9250Q39994571-A97647A2-A1B4-4500-AA7E-C2A430CE4084Q40330962-841DBB69-7AF5-442A-A938-AACA1D59FA2EQ40330969-8E89B46F-83AE-40DD-B906-0B9816C393C3Q40972284-F24375AD-0508-404F-81BE-7C4F3EE29A75Q41213700-B1DCB3F5-6837-450A-B1E6-304658B287DEQ41214072-2BE00960-6558-4B35-AA59-6E123E2BA69FQ41214112-84E95896-8F17-4ED4-A7F9-96DF27250CA0Q41247712-ACAB19FE-0417-4808-B0FF-B31EBC4D4BC8Q41258160-A2B736E2-BF5B-4133-9B6E-A53F6042CC98Q41261144-DF4AF9D5-BD6B-445B-8C5A-856EBC178C94Q41294595-1C5CDFFA-9061-4EEE-87A0-B90AFB7CA452Q41460695-5EDF27F3-F565-403C-A98F-3E697E049280Q42159309-A67F9BFA-EEDF-493C-9C54-819ACFA877D1Q42740013-78B701F8-0A6F-4C59-B7EC-A7A8395BD1EBQ52129535-7E77C91C-AD5B-4139-BBBE-B170D27564CEQ54091887-BF21F056-B3F4-4190-AF95-EEEB29371A60
P2860
description
1959 nî lūn-bûn
@nan
1959 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1959 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1959年の論文
@ja
1959年論文
@yue
1959年論文
@zh-hant
1959年論文
@zh-hk
1959年論文
@zh-mo
1959年論文
@zh-tw
1959年论文
@wuu
name
Studies on enhanced fibrinolytic activity in man.
@ast
Studies on enhanced fibrinolytic activity in man.
@en
Studies on enhanced fibrinolytic activity in man.
@nl
type
label
Studies on enhanced fibrinolytic activity in man.
@ast
Studies on enhanced fibrinolytic activity in man.
@en
Studies on enhanced fibrinolytic activity in man.
@nl
prefLabel
Studies on enhanced fibrinolytic activity in man.
@ast
Studies on enhanced fibrinolytic activity in man.
@en
Studies on enhanced fibrinolytic activity in man.
@nl
P2093
P356
P1476
Studies on enhanced fibrinolytic activity in man.
@en
P2093
ALKJAERSIG N
FLETCHER AP
LINDEMEYER RI
P304
P356
10.1172/JCI103863
P407
P577
1959-05-01T00:00:00Z